Patient Preparation and Counseling, Therapeutic plasma exchange, Clinical Pathology - Full Vignette

Описание: A 35-year-old woman with common variable immunodeficiency presents with rapidly progressive leg weakness, sensory changes, facial diparesis, and respiratory compromise after recent travel and diarrheal illness. Given her immunodeficiency and acute neurologic symptoms, what critical epidemiologic and clinical considerations should inform patient counseling before therapeutic plasma exchange? How do the patient s presentation and evolving neuromuscular deficits shape your communication of risks and expectations for this procedure?

VIDEO INFO
Category: Patient Preparation and Counseling, Therapeutic plasma exchange, Clinical Pathology
Difficulty: Expert - Expert level - For those seeking deep understanding
Question Type: Epidemiology
Case Type: Rare Presentation

Explore more ways to learn on this and other topics by going to https://endlessmedical.academy/auth?h...

QUESTION
A 35-year-old woman with common variable immunodeficiency (CVID) presents to the emergency department with 4 days of ascending leg weakness, distal paresthesias, and difficulty climbing stairs after two weeks of non-bloody diarrhea and low-grade fever following travel for a tropical field program. She attends night school, works occasional construction shifts, and owns two cats. She drinks alcohol socially (3-4 drinks per week)....

OPTIONS
A. A single 1.0 plasma-volume exchange removes about two-thirds of the intravascular, immediately accessible IgG ( 63% by first-order kinetics), with partial redistribution from extravascular compartments leaving roughly 30-40% net reduction at 24-48 hours unless additional exchanges are performed.
B. A single 1.0 plasma-volume exchange typically removes 70-75% of intravascular IgG with negligible redistribution thereafter, so the net reduction remains essentially unchanged over the next 48 hours without further sessions.
C. A single 1.0 plasma-volume exchange removes about one-half of intravascular IgG initially, but rapid equilibration restores levels nearly to baseline within 12 hours unless plasma (not albumin) is used as replacement fluid.
D. A single 1.0 plasma-volume exchange removes 63% of intravascular IgG and prevents clinically meaningful rebound over 24-48 hours when 5% albumin is used, with rebound occurring mainly when fresh frozen plasma is the replacement fluid.

CORRECT ANSWER
A. A single 1.0 plasma-volume exchange removes about two-thirds of the intravascular, immediately accessible IgG ( 63% by first-order kinetics), with partial redistribution from extravascular compartments leaving roughly 30-40% net reduction at 24-48 hours unless additional exchanges are performed.

EXPLANATION
The key counseling point is that therapeutic plasma exchange follows first-order kinetics for intravascular macromolecules like IgG. Exchanging one plasma volume removes a constant fraction of the immediately accessible, intravascular IgG-about 1 - e^(-1) 63%-not a fixed mass. Because most IgG resides outside the vasculature and redistributes back over 24-48 hours, the net reduction measured the next day is usually smaller, on the order of 30-40% unless additional exchanges are performed in a serial regimen. This is the empiric basis for scheduling repeated 1.0 plasma-volume exchanges every 24-48 hours in acute, antibody-mediated neurologic disease....


Further reading:

Links to sources are provided for optional further reading only. The questions and explanations are independently authored and do not reproduce or adapt any specific third-party text or content.

---------------------------------------------------

Our cases and questions come from the https://EndlessMedical.Academy quiz engine - multi-model platform. Each question and explanation is forged by consensus between multiple top AI models (i.e. Open AI GPT, Claude, Grok, etc.), with automated web searches for the latest research and verified references. Calculations (e.g. eGFR, dosages) are checked via code execution to eliminate errors, and all references are reviewed by several AIs to minimize hallucinations.

Important note: This material is entirely AI-generated and has not been verified by human experts; despite stringent consensus checks, perfect accuracy cannot be guaranteed. Exercise caution - always corroborate the content with trusted references or qualified professionals, and never apply information from this content to patient care or clinical decisions without independent verification.

Clinicians already rely on AI and online tools - myself included - so treat this content as an additional focused aid, not a replacement for proper medical education. Visit https://endlessmedical.academy for more AI-supported resources and cases.

This material can not be treated as medical advice. May contain errors.

---------------------------------------------------